Austin, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Fecal Calprotectin Testing Market Size & Trends: According to SNS Insider, the global Fecal Calprotectin Testing Market was valued at USD 4.51 billion in 2023 ...

A calprotectin stool test detects levels of calprotectin in stool. This protein indicates bowel inflammation. It can help diagnose and monitor conditions such as inflammatory bowel disease (IBD). A ...

Fecal calprotectin is a highly sensitive assay that measures inflammation present in the intestinal tract. Gastroenterologists are increasingly ordering fecal calprotectin to screen and monitor ...

High levels of calprotectin indicate IBD, while low or normal levels indicate IBS. In the United States, an estimated 3.1 million adults have been diagnosed with IBD. Currently, fecal calprotectin ...

SALEM, N.H., May 8, 2025 /PRNewswire/ -- American Laboratory Products Company, Ltd. ("ALPCO"), a global provider of specialty diagnostic solutions, announced the European commercial launch of its ...

BÜHLMANN, a company based in Germany, launched IBDoc, an at-home, in-vitro diagnostic test for gastrointestinal conditions, including some inflammatory bowel diseases, according to an IBD News Today ...

SAN DIEGO, Feb. 23, 2021 /PRNewswire/ -- ProciseDx Inc. announced today that it has received CE mark for its Fecal Calprotectin (Procise FCP™) point of care tests for use on the ProciseDx™ system.

(MENAFN- GlobeNewsWire - Nasdaq) SNS Insider's new report reveals that the U.S. Fecal Calprotectin Testing market, valued at USD 1.31 billion in 2023, will grow at a CAGR of 11.7% through 2032 amid ...